OSBP2 and hepatocellular carcinoma: These observations suggested that OSBP2 and UNC119B inhibited the HCC immunotherapy response as well as susceptibility to chemotherapy, indicating that OSBP2 and UNC119B might serve as crucial therapeutic targets for HCC.